Skip to main content
SpringerLink
Log in

Rifampicin: A Review

  • Evaluations on New Drugs
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Acocella, G.; Nicolis, F.B., and Lamarina, A.: A study on the kinetics of rifampicin in men. Chemotherapia 5: 87 (1967).

    Google Scholar 

  • Annotation. Lancet 1: 976 (1969).

  • Arioli, V.; Pallanza, R.; Furesz, S., and Carniti, G.: Rifampicin: a new rifamycin. 1. Bacteriological studies. Arzneimittel-Forschung 17: 523 (1967).

    PubMed  CAS  Google Scholar 

  • Atlas, E. and Turck, M.: Laboratory and clinical evaluation of rifampicin. American Journal of the Medical Sciences 256: 247 (1968).

    CAS  Google Scholar 

  • Balea, T.; Marche, C., and Marche, J.: Effets hépato-biliaires de l’association rifampicine-isoniazide. Thérapie 25: 125 (1970).

    PubMed  CAS  Google Scholar 

  • Bariffi, F.; DiFilippo, A., and Marinelli, M.: L’attività terapeutica della rifampicina nei processi cronici della tubercolosi polmonare. Archivio di tisiologia e delle malattie dell’apparato respiratorio 23: 329 (1968).

    Google Scholar 

  • Baronti, A. and Lukinovitch, N.: A pilot trial of rifampicin in tuberculosis. Tubercle (Lond.) 49: 80 (1968).

    Google Scholar 

  • Batten, J.: Rifampicin in treatment of experimental tuberculosis in mice. Tubercle (Lond.) 50: 294 (1969).

    CAS  Google Scholar 

  • Becker, Y.; Asher, Y.; Himmel, N., and Zakay-Rones, Z.: Rifampicin inhibition of trachoma agent in vivo. Nature 224: 33 (1969b).

    PubMed  CAS  Google Scholar 

  • Becker, Y. and Zakay-Rones, Z.: Rifampicin: a new antitrachoma drug. Nature 222: 851 (1969a).

    PubMed  CAS  Google Scholar 

  • Ben-Ishai, Z.; Heller, E.; Goldblum, N., and Becker, Y.: Rifampicin poxvirus and trachoma agent. Nature 224: 29 (1969).

    PubMed  CAS  Google Scholar 

  • Blajchman, M.A.; Lowry, R.C.; Pettit, J.E, and Stradling, P.: Rifampicin-induced immune thrombocytopenia. British Medical Journal 3: 24 (1970).

    PubMed  CAS  Google Scholar 

  • Boman, G.; Borgå, O.; Hanngren, Å.; Malmborg, Anna-Stina, and Sjöqvist, F.: Pharmacokinetic interactions between the tuberculostatics rifampicin, para-aminosalicylic acid and isoniazid. Acta Pharmacologica et Toxicologica 28 (suppl. 1): 15 (1970).

    PubMed  CAS  Google Scholar 

  • Boman, G.; Hanngren, Å.; Malmborg, Anna-Stina; Borgå, O., and Sjöqvist, F.: Drug interaction: decreased serum concentrations of rifampicin when given with PAS. Lancet 1: 800 (1971).

    PubMed  CAS  Google Scholar 

  • Brickner, P.W.: Rifampicin: clinical studies with a new antibiotic. Journal of Clinical Pharmacology and New Drugs 9: 243 (1969).

    Google Scholar 

  • Canetti, G.; Le Lirzin, M.; Porven, G.; Rist, N., and Grumbach, F.: Some comparative aspects of rifampicin and isoniazid. Tubercle (Lond.) 49: 367 (1968).

    CAS  Google Scholar 

  • Carratu, L.; Piazza, R., and Massei, V.: The integrity of various organs and systems in patients treated with rifampicin. Archivio di tisiologia e delle malattie dell’apparato respiratorio 22: 463 (1967).

    PubMed  CAS  Google Scholar 

  • Citron, K.M. and May, J.R.: Rifampicin antibiotics in chronic purulent bronchitis. Lancet 2: 982 (1969).

    PubMed  CAS  Google Scholar 

  • Clark, J. and Wallace, A.: The susceptibility of mycobacteria to rifamide and rifampicin. Tubercle (Lond.) 48: 144 (1967).

    CAS  Google Scholar 

  • Cobbold, R.J.C.; Morrison, G.D., and Willcox, R.R.: Treatment of gonorrhoea with single oral doses of rifampicin. British Medical Journal 4: 681 (1968).

    PubMed  CAS  Google Scholar 

  • Cohn, H.D.: Clinical studies with a new rifampicin derivative. Journal of Clinical Pharmacology and New Drugs 9: 118 (1969).

    CAS  Google Scholar 

  • Curci, G. and Loscalzo, B.: Atti del 18mo Congresso Italiano di Tisiologia, Milano 23: 293 (1966).

    Google Scholar 

  • Curci, G.; Ninni, A., and Di Mezza, F.: Indagini sperimentali sulla farmacocinetica della rifampicina. Archivio di tisiologia e delle malattie dell’apparato respiratorio 23: 293 (1968).

    PubMed  CAS  Google Scholar 

  • Daddi, G.; Cornia, F.; Grossi, C.; Perna, G., and Scarpazza, G.: Prime osservazioni sull’attivitá della rifampicina per via orale nella tubercolosi polmonare cronica. Giornale italiano delle malattie del torace 21: 131 (1967).

    PubMed  CAS  Google Scholar 

  • Dans, P.E.; McGehee, R.F.; Wilcox, Claire, and Finland, M.: Rifampicin: Antibacterial activity in vitro and absorption and excretion in normal young men. American Journal of the Medical Sciences 259: 120 (1970).

    PubMed  CAS  Google Scholar 

  • Deal, W.B. and Sanders, E.: Efficacy of rifampicin in treatment of meningococcal carriers. New England Journal of Medicine 281: 641 (1969).

    PubMed  CAS  Google Scholar 

  • De la Roy, Y. de R.; Beauchant, G.; Breuil, K., and Patte,F.: Diminution du taux sérique de rifampicine par le phénobarbital. Presse Méd. 79: 350 (1971).

    Google Scholar 

  • Del Bono, M.; DiFilippo, A., and Lorenzoni, E.: Comportamento dell’allergia tubercolinica in corso di trattamento con rifampicina. Archivio di tisiologia e delle malattie dell’apparato respiratorio 22: 477 (1967).

    PubMed  Google Scholar 

  • Del Bono, M. and Sisti, F.: Su di un caso di ipersensibilità alle rifamicine. Archivio di tisiologia e delle malattie dell’apparato respiratorio 22: 507 (1967).

    PubMed  Google Scholar 

  • De Michele, F.; Iodice, F., and Lappa, B.: Prime osservazioni sull’attività terapeutica della rifampicina associata alla streptomicina o alla isomazide. Archivio di tisiologia e delle malattie dell’apparato respiratorio 23: 377 (1968).

    PubMed  Google Scholar 

  • Dettli, L. and Spring, P.: Factors influencing drug elimination in man II. Farmaco 23: 105 (1968).

    Google Scholar 

  • Devine, L.F.; Johnson, D.P.; Hagerman, C.R.; Pierce, W.E.; Rhode, S.L., and Peckinpaugh, R.O.: Rifampicin levels in serum and saliva and effect on the meningococcal carrier state. Journal of the American Medical Association 214: 1055 (1970).

    PubMed  CAS  Google Scholar 

  • Dickinson, J.M. and Mitchison, D.A.: In vitro studies on the choice of drugs for intermittent chemotherapy of tuberculosis. Tubercle (Lond.) 47: 370 (1966).

    Google Scholar 

  • Dickinson, J.M. and Mitchison, D.A.: Suitability of rifampicin for intermittent administration in the treatment of tuberculosis. Tubercle (Lond.) 51: 82 (1970).

    CAS  Google Scholar 

  • Dickinson, J.M.; Ellard, G.A., and Mitchison, D.A.: Suitability of isoniazid and ethambutol for intermittent administration in the treatment of tuberculosis. Tubercle (Lond.) 49: 351 (1968).

    CAS  Google Scholar 

  • Diggelmann, Heidi and Weissmann, C.: Rifampicin inhibits focus formation in chick fibroblasts infected with Rous Sarcoma virus. Nature 224: 1277 (1969).

    PubMed  CAS  Google Scholar 

  • Engbaek, H.C. and Vergmann, B.: Rifampicin in the treatment of drug-resistant tuberculosis. Scandinavian Journal of Respiratory Disease 51: 11 (1970).

    CAS  Google Scholar 

  • Ezekiel, D.H. and Hutchins, J.E: Another mutant of E. coli containing an altered RNA polymerase. Nature 220: 276 (1968).

    PubMed  CAS  Google Scholar 

  • Faine, S. and Knight, D.C.: Rapid microbiological assay of antibiotic in blood and other body fluids. Lancet 2: 375 (1968).

    PubMed  CAS  Google Scholar 

  • Fortuni, M.; Cicogna, A.; Princiotta, M.; Vagni, E., and Grossholz, G.: Primi risultati del trattamento della tubercolosi polmonare con rifampicina. Rivista della tubercolosi e delle malattie dell’apparato respiratorio 16: 290 (1968).

    Google Scholar 

  • Furesz, S.: Chemical and biological properties of rifampicin; in Freerksen, Orlowski and Thumim Antibiotica et Chemotherapia, vol. 16, p. 316 (Karger, Basel 1970).

  • Furesz, S.; Scotti, R.; Pallanza, R., and Mapelli, E.: Rifampicin: a new rifamycin absorption, distribution and elimination in man. Arzneimittel-Forschung 17: 534 (1967).

    PubMed  CAS  Google Scholar 

  • Grumbach, F.: Experimental in vivo studies of new antituberculosis drugs: capreomycin, ethambutol, rifampicin. Tubercle (suppl.) 50: 12 (1969).

    Google Scholar 

  • Grumbach, F.; Canetti, G., and Le Lirzin, M.: Rifampicin in daily and intermittent treatment of experimental murine tuberculosis with emphasis on late results. Tubercle (Lond.) 50: 280 (1969).

    CAS  Google Scholar 

  • Grumbach, F. and Rist, N.: The experimental tuberculostatic effect of rifampicin, a derivative of rifamycin SV. Revue de Tuberculose et de Pneumologie 31: 749 (1967).

    PubMed  CAS  Google Scholar 

  • Gyselen, A. and Simon-Pouthier, F.: Clinical results in first treatment and retreatment of advanced pulmonary tuberculosis with rifampicin. Tubercle (Lond.) 50: 328 (1969).

    Google Scholar 

  • Gyselen, A.; Verbist, L.; Cosemans, J.; Lacquet, L.M., and Vandenperch, E.: Rifampicin and ethambutol in the retreatment of advanced pulmonary tuberculosis. American Review of Respiratory Diseases 98: 933 (1968).

    CAS  Google Scholar 

  • Hartmann, G.; Honikel, K.O.; Knusel, F., and Neusch, J.: The specific inhibition of the DNA-directed RNA synthesis by rifampicin. Biochemica et Biophysica Acta 145: 843 (1967).

    CAS  Google Scholar 

  • Havel, A.; Adámek, L., and Šimonová, S.: Rifampicin in experimental investigations on mice; in Freerksen, Orlowski and Thumim Antibiotica et Chemotherapia, vol. 16, p. 406 (Karger, Basel 1970).

  • Heller, E.; Argaman, M.; Levy, H., and Goldblum, N.: Selective inhibition of vaccinia virus by the antibiotic rifampicin. Nature 222: 273 (1969).

    PubMed  CAS  Google Scholar 

  • Hellström, P-E. and Repo, U.K.: Capreomycin, ethambutol and rifampicin in apparently incurable pulmonary tuberculosis. Scandinavian Journal of Respiratory Diseases (suppl.) 69: 69 (1969)

    Google Scholar 

  • Hobby, Gladys L. and Lenert, Tulita F.: The antimycobacterial activity of rifampicin. American Review of Respiratory Diseases 97: 713 (1968).

    CAS  Google Scholar 

  • Hobby, Gladys L. and Lenert, Tulita F.: The action of rifampicin alone and in combination with other antituberculosis drugs. American Review of Respiratory Diseases 102: 462 (1970).

    CAS  Google Scholar 

  • Hollins, P.J. and Simmons, A.V: Jaundice associated with rifampicin. Tubercle (Lond.) 51: 328 (1970).

    CAS  Google Scholar 

  • Hugues, F.-C.; Marche, C., and Marche, J.: Effets hepatobiliaires de l’association rifampicine-isoniazide. Thérapie 24: 899 (1969).

    PubMed  CAS  Google Scholar 

  • Hugues, F.-C.; Marche, C., and Marche, J.: Effets hépatobiliaires de l’association rifampicine-prothionamide. Thérapie 25: 131 (1970).

    PubMed  CAS  Google Scholar 

  • Jouhar, A.J.: The rifamycin antibiotics — in retrospect and prospect. Journal of Therapeutics and Clinical Research 2: 17(1968).

    Google Scholar 

  • Kaspar, M.C. and Regli, J.: Rifampicin-Monotherapie bei chronischer, bazillärer Lungentuberkulose. Chemotherapia 4: 43 (1967).

    Google Scholar 

  • Konig, K.: Rifampicin in the treatment of urogenital tuberculosis. Cited in abstracts of papers presented at the 6th International Congress of Chemotherapy, August 10–15, 1969 and Post-Congress Symposium I, August 16–17, 1969, Tokyo, Japan, p. 280 (1969).

  • Konopka, E.A.; Zoganas, H.C.; Lewis, L., and Gelzer, J.: Chemotherapeutic activity of rifampicin against Gram-negative bacteria with reference to urinary tract infection in rats. Antimicrobial Agents and Chemotherapy 13: 519 (1968).

    Google Scholar 

  • Kradolfer, F.: Analyse der Wirksamkeit von Rifamycin-Derivaten und bekannten Therapeutika erster Ordnung und der murinen Tuberkulose. Chemotherapia 12: 369 (1967).

    Google Scholar 

  • Kunin, C.M.; Brandt, D., and Wood, H.: Bacteriologic studies of rifampicin, a new semisynthetic antibiotic. Journal of Infectious Diseases 119: 132 (1969).

    PubMed  CAS  Google Scholar 

  • Laumen, F.: Monotherapie und Kombinationstherapie mit Rifampicin bei 156 Tuberkuloseerkrankungen. Prax. Pneumol. 24: 158 (1970).Abstract in German Medi-cal Monthly 15: 654 (1970).

    PubMed  CAS  Google Scholar 

  • Leading article: British Medical Journal 2: 588(1969).

  • Lees, A.W.; Asgher, B.; Hashem, M.A., and Sinha, B.N.; Jaundice after rifampicin. British Journal of Diseases of the Chest 64: 90 (1970).

    PubMed  CAS  Google Scholar 

  • Lesobre, R.; Ruffino, J.; Teyssier, L.; Achard, F., and Brefort, G.: Les ictères au cours du traitement par la rifampicine. Revue de Tuberculose et de Pneumologie 33: 393 (1969).

    PubMed  CAS  Google Scholar 

  • Lorian, V. and Finland, M.: In vitro effect of rifampicin on mycobacteria. Applied Microbiology 17: 202 (1969).

    PubMed  CAS  Google Scholar 

  • Lucchesi, M. and Mancini, P.: Antimycobacterial activity of rifampicin; in Freerksen, Orlowski and Thumim Antibiotica et Chemotherapia, vol. 16, p. 431 (Karger, Basel 1970).

  • Lucchesi, M.; Pallotta, G.; Rossi, P., and Sbampato, M.: L’azione terapeutica della rifampicina, derivato 3-(4-metil-1-piperazinil-iminometil)-rifampicina SV, nella tubercolosi polmonare. Annali dell’Istituto “Carlo Forlanini” 27: 199 (1967).

    CAS  Google Scholar 

  • Lucchesi, M. and Rossi, P.: Impiego clinico della rifampicina nella tubercolosi polmonare dell’adulto. Rivista della tubercolosi e delle malattie dell’apparato respiratorio 16: 260 (1968).

    Google Scholar 

  • Maggi, N.F.; Furesz, S.; Pallanza, R., and Pelizza, G.: Rifampicin de-acetylation in the human organism. Arzneimittel-Forschung 19: 643 (1969).

    Google Scholar 

  • Maggi, N.; Pasqualucci, C.R.; Ballotta, R., and Sensi, P.: Rifampicin: a new orally active rifamycin. Chemotherapia 11: 285 (1966).

    CAS  Google Scholar 

  • Manten, A. and Van Wijngaarden, L.J.: Development of drug resistance to rifampicin. Chemotherapy 14: 93 (1969).

    PubMed  CAS  Google Scholar 

  • di Mauro, E.; Synder, L.; Marino, P.; Lamberti, A.; Coppo, A., and Tocchini-Valentini, G.P.: Rifampicin sensitivity of the components of DNA-dependent RNA polymerase. Nature 222: 533 (1969).

    PubMed  Google Scholar 

  • May, P.: Clinical findings with rifampicin in tuberculosis of the urogenital tract; in Freerksen, Orlowski and Thumim Antibiotica et Chemotherapia, vol. 16, p. 480 (Karger, Basel 1970).

  • McCabe, W.R. and Lorian, V.: Comparison of the antibacterial activity of rifampicin and other antibiotics. American Journal of the Medical Sciences 256: 255 (1968).

    PubMed  CAS  Google Scholar 

  • Michot, F.; Bürgi, M., and Büttner, J.: Rimactan (Rifampizin) und Antikoagulantientherapie. Schweizerische medizinische Wochenschrift 100: 583 (1970).

    PubMed  CAS  Google Scholar 

  • Monaco, A.: Il trattamento della tubercolosi polmonare con rifampicina practica sanatoriale. Rivista della tubercolosi e delle malattie dell’apparato respiratorio 16: 273 (1968).

    Google Scholar 

  • Moncalvo, F. and Moreo, G.: Ulteriori ricerche cliniche sull’impiego di una nuova rifamicina orale (rifampicinao rifaldazina) nella terapia della tubercolosi polmonare. Rivista di patologia e clinica della tubercolosi 40: 782 (1967).

    Google Scholar 

  • Moss, B.; Rosenblum, Edith N.; Katz, E., and Grimley, P.M.: Rifampicin: a specific inhibitor of vaccina virus assembly. Nature 224: 1280 (1969).

    PubMed  CAS  Google Scholar 

  • Murdoch, J.McC.; Spiers, C.F.; Wright, N., and Wallace, Edith T.: Rifampicin. Lancet 1: 1094(1969).

    PubMed  CAS  Google Scholar 

  • Nitti, V.: L’attività della rifampicina in vitro sui micobatteri atipici. Archivio di tisiologia e delle malattie dell’apparato respiratorio 22: 498 (1967).

    PubMed  CAS  Google Scholar 

  • Nitti, V.; Catena, E.; Bariffi, F., and Delli Veneri, F.: L’attività terapeutica della rifampicina nella tubercolosi polmonare. Archivio di tisiologia e delle malattie dell’apparato respiratorio 22: 417 (1967a).

    PubMed  CAS  Google Scholar 

  • Nitti, V.; Catena, E.; Ninni, A., and DiFilippo, A.: Indagini sperimentali sull’attività antimicobatterica della rifampicina. Archivio di tisiologia e delle malattie dell’apparato respiratorio 21: 867 (1966).

    PubMed  CAS  Google Scholar 

  • Nitti, V.; Catena, E.; Ninni, A., and DiFilippo, A.: Activity of rifampicin in experimental tuberculosis of the guinea pig. Chemotherapia 12: 369 (1967b).

    CAS  Google Scholar 

  • Nitti, V. and Ninni, A.: In vivo bactericidal activity of rifampicin in combination with other antimycobacterial agents. Chemotherapy 14: 356 (1969).

    PubMed  CAS  Google Scholar 

  • Pallanza, R.; Arioli, V.; Furesz, S., and Bolzoni, G.: Rifampicin: a new rifamycin. Arzneimittel-Forschung 17: 529 (1967).

    PubMed  CAS  Google Scholar 

  • Peard, Mary C.; Fleck, D.G.; Garrod, L.P., and Waterworth, Pamela M.: Combined rifampicin and erythromycin for bacterial endocarditis. British Medical Journal 4: 410 (1970).

    PubMed  CAS  Google Scholar 

  • Pechère, J.C. and Tancrède, C.: Changes in the levels of rifampicin in the serum and urine during the course of treatment. Pathologie et biologie 17: 155 (1969). Abstract in Abstracts of World Medicine 43: 564 (1969).

    PubMed  Google Scholar 

  • Pines, A.; Raafat, H., and Bundi, R.: The rifamycins with other drugs in the treatment of pulmonary tuberculosis: a report of 9 cases. Tubercle (Lond.) 48: 281 (1967).

    CAS  Google Scholar 

  • Pines, A.; Raafat, H., and Siddiqui, G.M.: Rifampicin and ethambutol in the treatment of drug resistant and far advanced pulmonary tuberculosis. Journal of the Irish Medical Association 63: 82 (1970).

    PubMed  CAS  Google Scholar 

  • Porpáczy, P.: Rifampicin in the treatment of chronic urinary tract infections with Gram-negative bacteria. Proceedings of the 6th International Congress of Chemotherapy, Tokyo. A10d-6: 230, abstract (1969).

    Google Scholar 

  • Radenbach, K.L.: Results of clinical studies with capreomycin, ethambutol and rifampicin in the Heckeshorn Hospital, Berlin. Scandinavian Journal of Respiratory Diseases (suppl.) 69: 43 (1969).

    CAS  Google Scholar 

  • Rees, R.J.W.; Pearson, J.M.H., and Walters, M.F.R.: Experimental and clinical studies of rifampicin in treatment of leprosy. British Medical Journal 1: 89 (1970).

    PubMed  CAS  Google Scholar 

  • Rocha, H.P. and Sanchez, A.S.: Use of a new rifamycin SV derivative in chronic urinary infections. Arzneimittel-Forschung 20: 101 (1970).

    Google Scholar 

  • Sanchez Sañudo, L.; Ricart, J.M., and Perli, E.: Tratamiento de la gonorrea con rifampicina. D’ia médico (Argentina) 41: 952 (1969).

    Google Scholar 

  • Spring, P. and Dettli, L.: Über die Pharmakokinetik des Rifampizins bei normaler und bei pathologisch veränderter Elimination. Chemotherapia 5: 95 (1967).

    Google Scholar 

  • Stottmeier, K.D.; Kubica, G.P., and Woodley, C.L.: Antimycobacterial activity of rifampicin. Applied Microbiology 17: 862 (1969).

    Google Scholar 

  • Subak-Sharpe, J.; Timbury, M.C., and Williams, J.F.: Rifampicin inhibits the growth of some mammalian viruses. Nature 222: 341 (1969).

    PubMed  CAS  Google Scholar 

  • Tafton, H.M. and Lind, H.E.: The treatment of urinary tract infections with a new antibiotic. Clinical Medicine 77: 30 (1970).

    Google Scholar 

  • Tan, K.B. and McAuslan, B.R.: Effect of rifampicin on poxvirus protein synthesis. Journal of Virology 6: 326 (1970).

    PubMed  CAS  Google Scholar 

  • Tocchini-Valentini, G.P.; Marino, P., and Colvill, A.J.: Mutant of E. coli containing an altered RNA polymerase. Nature 220: 275 (1968).

    PubMed  CAS  Google Scholar 

  • Vall-Spinosa, A.; Lester, W.; Moulding, R.; Davidson, P.T., and McClatchy, J.K.: Rifampin in the treatment of drug-resistant Mycobacterium tuberculosis infections. New England Journal of Medicine 283: 616 (1970).

    PubMed  CAS  Google Scholar 

  • Verbist, L.: Tuberculostatic activity of rifampicine in vitro and in vivo presented at 5th International Congress of Chemotherapy, Vienna, 1967, p. 521 (1967).

  • Verbist, L. and Gyselen, A.: Antituberculous activity of rifampicin in vitro and in vivo and the concentrations obtained in human blood. American Review of Respiratory Diseases 98: 923 (1968).

    CAS  Google Scholar 

  • Virchow, Chr. and Flemming, J.: Rifampizin als Tuberkulostatikum. Deutsche medizinische Wochenschrift 92: 2217 (1967).

    PubMed  CAS  Google Scholar 

  • Viswanathan, R.; Rao, P.U.; Dusaj, M.; Sarkar, D.K., and Bhakta, U.S.: Control clinical trial with rimactane in fresh, untreated cases of pulmonary tuberculosis. Indian Journal of Medical Research 58: 519 (1970).

    PubMed  CAS  Google Scholar 

  • Wardell, W.M. and McQueen, E.G.: Urinary excretion of rifampicin and its metabolites as an index of rifampicin blood levels. New Zealand Medical Journal 72: 393 (1970).

    PubMed  CAS  Google Scholar 

  • Wardell, W.M.; Yule, A.G.; Ballard, D.L., and Forsyth, A.: Modification of the pH method of antibiotic bioassay for penicillins, cephalosporins and other antibiotics. Proceedings of the University of Otago Medical School 48: 24 (1970).

    Google Scholar 

  • Wäre, M.: Rifampicin in the treatment of resistant pulmonary tuberculosis. Scandinavian Journal of Respiratory Diseases (suppl.) 72: 113 (1970).

    Google Scholar 

  • Wäre, M.; Heinivaara, O.; Elo, R., and Tola, E.: Clinical experience of the treatment of drug-resistant pulmonary tuberculosis with rifampicin combined with ethambutol and capreomycin. Scandinavian Journal of Respiratory Diseases (suppl.) 69: 59 (1969).

    Google Scholar 

  • Wehrli, W. and Staehelin, M.: Interaction of rifamycin with RNA polymerase. Proceedings of the 6th International Congress of Chemotherapy, Tokyo. B1-5: 392, abstract (1969).

    Google Scholar 

  • Zakay-Rones, Z. and Becker, Y.: Antipoxvirus activity of rifampicin associated with hydrazone side chain. Nature 226: 1162 (1970).

    PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rifampicin: A Review. Drugs 1, 354–398 (1971). https://doi.org/10.2165/00003495-197101050-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-197101050-00002

Search

Navigation